Lv2
150 积分 2021-08-27 加入
What influences the activity of Degrader−Antibody conjugates (DACs)
2个月前
已完结
Targeting cancer with small-molecule pan-KRAS degraders
5个月前
已完结
Targeting cancer with small molecule pan-KRAS degraders
8个月前
已完结
Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs
9个月前
已完结
Antibody–drug conjugates: Recent advances in payloads
9个月前
已完结
520LBA (PB-520) LBA Posters: Preclinical characterization of LY4175408, a novel PTK7 targeting antibody-drug conjugate, utilizing exatecan via a hydrophilic polysarcosine linker platform
9个月前
已完结
In Silico-Driven THIOMAB Approach for Stable PROTAC Conjugates by Docking Payloads in Antibody Cavities
9个月前
已完结
皖公网安备34019202002308
